Pasithea Therapeutics Corp.
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Pasithea Therapeutics Corp. generated cash of -$13,425, which is more than the previous year. Cash used in financing activities reached the amount of -$3,726,416 last year. Net change in cash is therefore -$16,756.

Cash Flow

Pasithea Therapeutics Corp. (NASDAQ:KTTA): Cash Flow
2020 -38.68K 0 282.33K
2021 -3.17M -21.50K 55.92M
2022 -14.56M -2.06M -3.20M
2023 -13.42K 399.00K -3.72M

KTTA Cash Flow Statement (2020 โ€“ 2023)

2023 2022 2021 2020
Cash at beginning of period
33.08M52.96M243.65K0
Operating activities
Net income
-15.50M-13.93M-2.17M-40.98K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
648.45K32.37K1.37K0
Stock-based compensation expense
592835.06K471.25K0
Deferred income tax benefit 592835.06K471.25K0
Changes in operating assets and liabilities:
Accounts receivable, net
0000
Inventories
0000
Accounts payable
0831.64M440.67K0
Cash generated by operating activities
-13.42K-14.56M-3.17M-38.68K
Investing activities
Purchases Of Investments
0000
Investments In Property Plant And Equipment
-34.30K-2.13M-21.50K0
Acquisitions Net
077.06K00
Cash generated by investing activities
399.00K-2.06M-21.50K0
Financing activities
Common Stock Issued
0050.23M282.33K
Payments for dividends
0000
Repurchases of common stock
-3.72M-3.20M00
Repayments of term debt
0000
Cash used in financing activities
-3.72M-3.20M55.92M282.33K
Net Change In Cash
-16.75K-19.81M52.72M243.65K
Cash at end of period
16.33M33.14M52.96M243.65K
Data sourceData sourceData source